Clinical Development

candle candles

Biotech

Biopsies illuminate potential of Candel's prostate cancer drug

Five months after revealing results of a prostate cancer trial, Candel has shown more data from the study, bolstering the value of CAN-2409.

Kevin Dunleavy May 22, 2025 6:57pm

White arrow on a road pointing to the rising sun

Pfizer ties PD-1 drug to 32% cancer risk reduction in phase 3

Apr 28, 2025 7:25am

Hiker having trouble climbing mountain

ALX Oncology doubles down as lead asset fails 2 phase 2 trials

Apr 25, 2025 2:25pm

Blood pressure monitor next to toy heart

Large trial reveals link between lowered BP and dementia risk

Apr 24, 2025 11:33am

pivot change turnaround direction walk away

Sanofi's oral TNF asset misses mark in phase 2 psoriasis trial

Apr 24, 2025 4:46am

obesity drugs

Ascletis sees no benefit to high, fast oral GLP-1 dose titration

Apr 23, 2025 7:25am